# Infectious Diseases (travel medicine) Referral

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Pierre Le Moyne d'Iberville (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET014-SYN-TD
- Date: 1705-02-17
- Fictional facility: St. Posthumous Health Center
- Fictional author: Marguerite Delacroix-Boateng, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- To: Jean-Baptiste Okonkwo-Hale, MD, Infectious Diseases (travel medicine)
- Urgency: Within two weeks; same day if he develops a fever

## Referral question

Three episodes of fever with shaking chills and sweats in two years, each beginning months after naval service in malaria-endemic areas, the first called malaria abroad and treated with chloroquine alone, in a 43-year-old naval commander who is afebrile today. Please establish whether these are malaria relapses, advise on antirelapse treatment, and plan his pre-travel care for a deployment to French Guiana and the French Antilles expected early next year. **S**

## Questions for the consultant

1. Are these relapses of P. vivax (or P. ovale) malaria, and is any further test needed?
2. What treatment do you recommend now, given the normal G6PD result?
3. What follow-up tests and relapse surveillance are needed?
4. Which vaccines, including yellow fever, does he need for French Guiana and the Antilles, and when?
5. What malaria chemoprophylaxis and other protection do you advise for the deployment, and is terminal prophylaxis needed on return?

## Pertinent history

Three febrile attacks in two years, each lasting about a week with chills every other day, drenching sweats and headache; the first diagnosed abroad as malaria on a smear, species not recorded, and treated with chloroquine alone; the later two treated with chloroquine without testing; the last ended six weeks ago. Earlier service on the Caribbean coast of Central America and in the Gulf of Mexico. No other illness, no regular medicines, no allergies. Afebrile today; temperature 36.7 C, blood pressure 124/78, pulse 70; spleen not palpable. Thick and thin smears and the rapid antigen test today are negative; Plasmodium species PCR sent to the reference laboratory. Hemoglobin 13.0 g/dL, platelets 141 x10^3/uL, white cells 5.6 x10^3/uL, bilirubin 1.1 mg/dL, ALT 34 U/L, AST 29 U/L, creatinine 0.98 mg/dL (eGFR 98), glucose 92 mg/dL. Quantitative G6PD activity 11.8 U/g Hb, normal. He expects to command a deployment to French Guiana and the French Antilles early next year, with months ashore and possible inland river work, and fears an attack at sea. **S**

- Pierre Le Moyne d'Iberville was born on July 16, 1661, in Montreal (Ville-Marie), New France, and was baptized there on July 20, 1661. He was the third son of Charles Le Moyne de Longueuil et de Châteauguay and Catherine Thierry. **D**
- The name d'Iberville came from a fief held by his father's family near Dieppe, and d'Ardillières from a property he acquired in Aunis near Rochefort. He was the first person born in Canada to receive the cross of the order of Saint-Louis. **D**
- He fought the English in Hudson Bay and James Bay from 1686: the capture of the James Bay posts in 1686, the Albany River in 1688 to 1689, New Severn in 1690, York Fort (renamed Fort Bourbon) in 1694, and in 1697 the naval battle near York Factory in which his ship, the Pélican, defeated English warships and was itself lost, followed by the surrender of the fort. **D**
- His biographer records that scurvy and exposure killed 25 of the English in the winter of 1688 to 1689 on the Albany River, and that in 1694 at York Fort scurvy killed many men on both sides. **D**
- In 1696 to 1697 he led a campaign against the English: Fort William Henry at Pemaquid capitulated on August 15, 1696, and in Newfoundland St John's surrendered on November 30 after a brief siege; the campaign destroyed 36 settlements, killed about 200 people and took about 700 prisoners. **D**
- He led the expeditions that began the French colony of Louisiana: in April 1699 he chose a site near the entrance of Biloxi Bay, near present-day Ocean Springs, Mississippi, for Fort Maurepas; in 1700 he built a fort on the Mississippi; and on his third voyage he began Fort Saint-Louis at Mobile. He left Louisiana in April 1702 and did not return. **D**
- Sailing from La Rochelle on September 29, 1701, on his third voyage to Louisiana, he was forced by illness to put in at Pensacola. **D**
- His biographer writes that he had attacks of malaria that recurred several times from 1702 to 1705 and that his deteriorating health thwarted planned expeditions to Louisiana; 64 Parishes writes that illness kept him from the expedition of 1703. **D**
- Despite his poor health, he was well enough in 1705 to be entrusted with preparing an armament, and early in 1706 he sailed from France with a squadron of twelve vessels against the English in the West Indies. **D**
- His biographer places the births of three of his children at La Rochelle, in 1698, 1701 and 1705. **D**

3 later historical claims are omitted because they describe events after the index age. See the teaching note.

Baseline: Hemoglobin: 13 g/dL (low); White cell count: 5.6 10*3/uL; Platelets: 141 10*3/uL (low); Sodium: 139 mmol/L; Potassium: 4.1 mmol/L; Creatinine: 0.98 mg/dL; Glucose: 92 mg/dL; ALT: 34 U/L; AST: 29 U/L; Total bilirubin: 1.1 mg/dL; G6PD activity: 11.8 U/g{Hb}; eGFR: 98 mL/min/1.73 m². All results are synthetic.

BP 124/78 mmHg; pulse 70 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 68.4 kg; BMI 22.3 kg/m². All vital signs are synthetic.

## Current medications

- No current medications. **S**

## Plan so far

- Malaria testing between attacks: thick and thin blood smears, rapid antigen test, and Plasmodium species PCR sent to the reference laboratory; quantitative G6PD activity before any primaquine; blood count, kidney and liver tests. Guideline: Treatment of Uncomplicated Malaria (clinical guidance) (2026) **S**
- Fever action plan: a blood smear the same day for any fever, at home, at sea or after travel; carry a card stating his malaria history. Guideline: Treatment of Uncomplicated Malaria (clinical guidance) (2026); CDC Yellow Book: Health Information for International Travel, 2026 edition. Malaria (2026) **S**
